rs28943594

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000414.4(HSD17B4):​c.2182A>G​(p.Met728Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00629 in 1,612,746 control chromosomes in the GnomAD database, including 401 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 194 hom., cov: 32)
Exomes 𝑓: 0.0040 ( 207 hom. )

Consequence

HSD17B4
NM_000414.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.51

Publications

8 publications found
Variant links:
Genes affected
HSD17B4 (HGNC:5213): (hydroxysteroid 17-beta dehydrogenase 4) The protein encoded by this gene is a bifunctional enzyme that is involved in the peroxisomal beta-oxidation pathway for fatty acids. It also acts as a catalyst for the formation of 3-ketoacyl-CoA intermediates from both straight-chain and 2-methyl-branched-chain fatty acids. Defects in this gene that affect the peroxisomal fatty acid beta-oxidation activity are a cause of D-bifunctional protein deficiency (DBPD). An apparent pseudogene of this gene is present on chromosome 8. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
HSD17B4 Gene-Disease associations (from GenCC):
  • d-bifunctional protein deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Perrault syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Perrault syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_000414.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0021131337).
BP6
Variant 5-119541965-A-G is Benign according to our data. Variant chr5-119541965-A-G is described in ClinVar as Benign. ClinVar VariationId is 226670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0939 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD17B4NM_000414.4 linkc.2182A>G p.Met728Val missense_variant Exon 24 of 24 ENST00000510025.7 NP_000405.1 P51659-1A0A0S2Z4J1B2R659

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSD17B4ENST00000510025.7 linkc.2182A>G p.Met728Val missense_variant Exon 24 of 24 2 NM_000414.4 ENSP00000424940.3 P51659-1

Frequencies

GnomAD3 genomes
AF:
0.0285
AC:
4328
AN:
152078
Hom.:
192
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0963
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0104
Gnomad ASJ
AF:
0.0112
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00125
Gnomad OTH
AF:
0.0197
GnomAD2 exomes
AF:
0.00828
AC:
2079
AN:
251230
AF XY:
0.00644
show subpopulations
Gnomad AFR exome
AF:
0.0972
Gnomad AMR exome
AF:
0.00496
Gnomad ASJ exome
AF:
0.00814
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00124
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00397
AC:
5798
AN:
1460550
Hom.:
207
Cov.:
30
AF XY:
0.00364
AC XY:
2648
AN XY:
726662
show subpopulations
African (AFR)
AF:
0.105
AC:
3500
AN:
33336
American (AMR)
AF:
0.00509
AC:
227
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.00889
AC:
232
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00233
AC:
201
AN:
86234
European-Finnish (FIN)
AF:
0.000318
AC:
17
AN:
53398
Middle Eastern (MID)
AF:
0.0134
AC:
77
AN:
5762
European-Non Finnish (NFE)
AF:
0.000973
AC:
1081
AN:
1111106
Other (OTH)
AF:
0.00767
AC:
463
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
260
520
780
1040
1300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0285
AC:
4342
AN:
152196
Hom.:
194
Cov.:
32
AF XY:
0.0271
AC XY:
2013
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0964
AC:
4000
AN:
41508
American (AMR)
AF:
0.0104
AC:
159
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
39
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00208
AC:
10
AN:
4818
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10604
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00125
AC:
85
AN:
68024
Other (OTH)
AF:
0.0194
AC:
41
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
210
420
630
840
1050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0111
Hom.:
150
Bravo
AF:
0.0325
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0920
AC:
405
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.0102
AC:
1234
Asia WGS
AF:
0.0100
AC:
37
AN:
3478
EpiCase
AF:
0.00147
EpiControl
AF:
0.00196

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Sep 18, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Met753Val in exon 25 of HSD17B4: This variant is not expected to have clinical s ignificance because it has been identified in 9.2% (405/4404) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs28943594). -

Bifunctional peroxisomal enzyme deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
May 24, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 16, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bifunctional peroxisomal enzyme deficiency;C0685838:Perrault syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Perrault syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
15
DANN
Benign
0.87
DEOGEN2
Benign
0.044
T;.;T;.;.;T;.;T;.;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.091
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.86
.;D;D;.;D;D;D;D;D;D
MetaRNN
Benign
0.0021
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.78
N;.;N;.;.;.;.;.;.;.
PhyloP100
3.5
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.41
N;N;.;.;N;.;.;N;N;.
REVEL
Benign
0.052
Sift
Benign
0.35
T;T;.;.;T;.;.;T;T;.
Sift4G
Benign
0.32
T;T;.;.;T;.;.;T;T;.
Polyphen
0.0
B;.;B;.;.;B;.;.;B;.
Vest4
0.17
MPC
0.060
ClinPred
0.013
T
GERP RS
3.5
Varity_R
0.077
gMVP
0.38
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28943594; hg19: chr5-118877660; API